A Multicenter, Prospective, Non-interventional Observation Study to Evaluate the Safety and Effectiveness of OAD Triple Therapy in Korean Type 2 Diabetic Mellitus Patients
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
A multicenter, prospective, non-interventional observation study to evaluate the safety and effectiveness of OAD triple therapy in Korean Type 2 diabetic mellitus patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Patients with type 2 diabetes who are 19 years of age or older at the time of enrollment.
• Continued DPP-4i or SGLT-2i oral hypoglycemic combination therapy with metformin for at least 8 weeks prior to enrollment.
• 7.0% ≤ HbA1c \< 10.0% based on laboratory tests performed within 4 weeks of enrollment.
• Voluntarily give written informed consent after being told about the study.
Locations
Other Locations
Republic of Korea
Seoul National University Bundang Hospital
RECRUITING
Seongnam-si
Contact Information
Primary
Soo Lim, M.D, Ph.D.
limsoo@snu.ac.kr
82-2-6373-0773
Time Frame
Start Date: 2024-03-16
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 10000
Treatments
Metformin/DPP4i/SGLT2i
Metformin + DPP4i 2-drug combination plus one of the SGLT-2i class of drugs.
Metformin/DPP4i/TZD
Metformin + DPP4i 2-drug combination plus one of the TZD class of drugs.
Metformin/SGLT2i/DPP4i
Metformin + SGLT2i 2-drug combination plus one of the DPP4i class of drugs.
Metformin/SGLT2i/TZD
Metformin + SGLT2i 2-drug combination plus one of the TZD class of drugs.
Related Therapeutic Areas
Sponsors
Leads: Chong Kun Dang Pharmaceutical